We are live on
!
Find out more
ECP
Elk Creek Partners Portfolio holdings
AUM
$582M
1-Year Est. Return
10.23%
This Fund
S&P 500
This Quarter
Est. Return
-3.28%
1 Year Est. Return
-10.23%
3 Year Est. Return
+16.39%
5 Year Est. Return
+41.52%
10 Year Est. Return
–
AUM
$1.16B
AUM Growth
-$175M
(-13%)
Cap. Flow
-$71.1M
Cap. Flow
% of AUM
-6.11%
Top 10 Holdings %
Top 10 Hldgs %
23.85%
Holding
127
New
3
Increased
41
Reduced
72
Closed
11
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CLVS
Clovis Oncology, Inc.
CLVS
|
+$16.6M |
| 2 |
Karyopharm Therapeutics
KPTI
|
+$11.5M |
| 3 |
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
|
+$10.8M |
| 4 |
Ligand Pharmaceuticals
LGND
|
+$10.1M |
| 5 |
MDRX
Veradigm Inc. Common Stock
MDRX
|
+$8.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WAGE
WageWorks, Inc.
WAGE
|
+$21M |
| 2 |
MDCO
Medicines Co
MDCO
|
+$13.7M |
| 3 |
MasTec
MTZ
|
+$13.5M |
| 4 |
EFII
Electronics for Imaging
EFII
|
+$13.2M |
| 5 |
IPHI
INPHI CORPORATION
IPHI
|
+$12.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 27.95% |
| 2 | Technology | 17.01% |
| 3 | Industrials | 12.32% |
| 4 | Consumer Discretionary | 11.44% |
| 5 | Communication Services | 11.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Raymond James Financial
RJF
$33.8B
| $4.19M | 0.36% |
76,248
-219
| -0.3% | -$11.9K |
|
|
BKI
102
DELISTED
Black Knight, Inc. Common Stock
BKI
| $3.9M | 0.34% |
63,845
-179
| -0.3% | -$11.1K |
|
|
VRAY
103
DELISTED
ViewRay, Inc.
VRAY
| $3.83M | 0.33% |
1,322,339
+114,975
| +10% | +$681K |
|
104
Trimble
TRMB
$13.2B
| $3.68M | 0.32% |
94,832
-8,021
| -8% | -$323K |
|
105
Marvell Technology
MRVL
$168B
| $3.62M | 0.31% |
145,148
-62,160
| -30% | -$1.56M |
|
|
TPIC
106
DELISTED
TPI Composites
TPIC
| $3.57M | 0.31% |
190,232
-17,727
| -9% | -$378K |
|
107
LKQ Corp
LKQ
$5.72B
| $3.22M | 0.28% |
102,305
-292
| -0.3% | -$7.99K |
|
|
COHR
108
DELISTED
Coherent Inc
COHR
| $3.05M | 0.26% |
19,855
-2,244
| -10% | -$324K |
|
109
AGCO
AGCO
$7.4B
| $2.64M | 0.23% |
34,837
-8,384
| -19% | -$616K |
|
|
SRCL
110
DELISTED
Stericycle Inc
SRCL
| $2.57M | 0.22% |
50,456
-147
| -0.3% | -$6.84K |
|
111
Webster Financial
WBS
$12.5B
| $2.51M | 0.22% |
53,518
-154
| -0.3% | -$7.28K |
|
|
STAY
112
DELISTED
Extended Stay America, Inc. Paired Share Unit
STAY
| $2.43M | 0.21% |
165,862
-477
| -0.3% | -$7.28K |
|
|
DSKE
113
DELISTED
Daseke, Inc. Common Stock
DSKE
| $2.38M | 0.21% |
953,539
-88,929
| -9% | -$250K |
|
114
PVH
PVH
$4B
| $2.22M | 0.19% |
25,185
-73
| -0.3% | -$6.1K |
|
|
ZAYO
115
DELISTED
Zayo Group Holdings, Inc.
ZAYO
| $1.89M | 0.16% |
55,604
-21,500
| -28% | -$724K |
|
|
PE
116
DELISTED
PARSLEY ENERGY INC
PE
| $1.78M | 0.15% |
105,876
-305
| -0.3% | -$5.24K |
|
117
G-III Apparel Group
GIII
$1.54B
| – | – |
-266,156
| Closed | -$7.83M |
|
118
Natera
NTRA
$38.3B
| – | – |
-308,077
| Closed | -$8.5M |
|
119
Dave & Buster's
PLAY
$377M
| – | – |
-259,946
| Closed | -$10.5M |
|
120
Red Robin
RRGB
$145M
| – | – |
-165,897
| Closed | -$5.07M |
|
|
TLGT
121
DELISTED
Teligent, Inc
TLGT
| – | – |
-451,599
| Closed | -$2.85M |
|
|
HOME
122
DELISTED
At Home Group Inc.
HOME
| – | – |
-622,944
| Closed | -$4.15M |
|
|
MDCO
123
DELISTED
Medicines Co
MDCO
| – | – |
-374,399
| Closed | -$13.7M |
|
|
AQ
124
DELISTED
Aquantia Corp. Common Stock
AQ
| – | – |
-386,151
| Closed | -$5.03M |
|
|
WAGE
125
DELISTED
WageWorks, Inc.
WAGE
| – | – |
-412,939
| Closed | -$21M |
|
Similar funds
BAC
AVC
OWD
PP
WWM
JA
PL
EA
Elk Creek Partners's Q3 2019 Portfolio in Review
As of Q3 2019, Elk Creek Partners held 127 positions worth $1.16B, down 13% from $1.34B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Elk Creek Partners withdrew a net $71.1M in Q3 2019, closing 11 positions and reducing 72 holdings. Its most notable exit was WageWorks, Inc., an estimated $21M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 25% a quarter earlier, followed by Technology and Industrials.
Against the trend, Elk Creek Partners opened a new position in Karyopharm Therapeutics worth $12.2M.
- Elk Creek Partners's largest Q3 2019 buy was Karyopharm Therapeutics: 84,715 shares worth $12.2M.
- Elk Creek Partners added most to Clovis Oncology, Inc. in Q3 2019, an estimated $16.6M increase.
- Elk Creek Partners's biggest Q3 2019 reduction was MasTec, cutting an estimated $13.5M.
- Elk Creek Partners fully exited WageWorks, Inc. in Q3 2019, selling an estimated $21M.
- Elk Creek Partners's ten largest holdings make up 24% of its $1.16B portfolio in Q3 2019.
- Elk Creek Partners opened 3 new positions and closed 11 in Q3 2019.
- Elk Creek Partners's portfolio value fell 13% quarter-over-quarter to $1.16B.
Based on Elk Creek Partners's 13F filing for Q3 2019, filed 13 Nov 2019.